Latest Insider Transactions at Axsome Therapeutics, Inc. (AXSM)
This section provides a real-time view of insider transactions for Axsome Therapeutics, Inc. (AXSM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Axsome Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Axsome Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 11
2024
|
Mark E Saad |
SELL
Open market or private sale
|
Direct |
11,016
-52.41%
|
$1,002,456
$91.31 P/Share
|
|
Sep 11
2024
|
Mark E Saad |
BUY
Exercise of conversion of derivative security
|
Direct |
11,016
+34.39%
|
$33,048
$3.67 P/Share
|
|
Aug 09
2024
|
Mark L. Jacobson Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
47,739
-89.2%
|
$4,010,076
$84.26 P/Share
|
|
Aug 09
2024
|
Mark L. Jacobson Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,739
+47.14%
|
$190,956
$4.04 P/Share
|
|
May 29
2024
|
Mark Coleman |
SELL
Open market or private sale
|
Direct |
5,248
-26.44%
|
$393,600
$75.14 P/Share
|
|
May 29
2024
|
Mark L. Jacobson Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,910
-57.77%
|
$585,340
$74.31 P/Share
|
|
May 29
2024
|
Mark L. Jacobson Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,693
+50.0%
|
$13,693
$1.3 P/Share
|
|
May 28
2024
|
Mark Coleman |
SELL
Open market or private sale
|
Direct |
5,249
-20.91%
|
$393,675
$75.21 P/Share
|
|
Apr 01
2024
|
Mark L. Jacobson Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
24,662
-100.0%
|
$1,898,974
$77.24 P/Share
|
|
Apr 01
2024
|
Mark L. Jacobson Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,662
+50.0%
|
$24,662
$1.3 P/Share
|
|
Mar 15
2024
|
Roger Jeffs |
SELL
Open market or private sale
|
Direct |
2,347
-1.91%
|
$166,637
$71.61 P/Share
|
|
Mar 15
2024
|
Roger Jeffs |
BUY
Exercise of conversion of derivative security
|
Direct |
2,347
+1.87%
|
$68,063
$29.91 P/Share
|
|
Mar 14
2024
|
Roger Jeffs |
SELL
Open market or private sale
|
Direct |
29,976
-11.02%
|
$2,068,344
$69.7 P/Share
|
|
Mar 14
2024
|
Roger Jeffs |
BUY
Exercise of conversion of derivative security
|
Direct |
29,976
+9.92%
|
$689,448
$23.78 P/Share
|
|
Sep 15
2023
|
Mark Coleman |
SELL
Open market or private sale
|
Indirect |
18,572
-4.4%
|
$1,392,900
$75.18 P/Share
|
|
Sep 15
2023
|
Mark Coleman |
SELL
Open market or private sale
|
Direct |
11,016
-30.5%
|
$826,200
$75.19 P/Share
|
|
Sep 15
2023
|
Mark Coleman |
BUY
Exercise of conversion of derivative security
|
Direct |
11,016
+23.37%
|
$33,048
$3.67 P/Share
|
|
Jan 03
2023
|
Mark Coleman |
BUY
Exercise of conversion of derivative security
|
Direct |
17,501
+41.08%
|
$17,501
$1.3 P/Share
|
|
Mar 15
2022
|
Mark Coleman |
BUY
Exercise of conversion of derivative security
|
Direct |
3,496
+31.52%
|
$3,496
$1.3 P/Share
|
|
Nov 19
2021
|
Roger Jeffs |
BUY
Open market or private purchase
|
Direct |
3,950
+3.17%
|
$146,150
$37.3 P/Share
|
|
Nov 18
2021
|
Mark Coleman |
BUY
Open market or private purchase
|
Indirect |
1,430
+0.17%
|
$50,050
$35.08 P/Share
|
|
Nov 18
2021
|
Nick Pizzie CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Indirect |
428
+47.08%
|
$14,552
$34.98 P/Share
|
|
Nov 18
2021
|
Nick Pizzie CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
527
+1.25%
|
$18,445
$35.5 P/Share
|
|
Nov 17
2021
|
Mark E Saad |
BUY
Open market or private purchase
|
Indirect |
300
+50.0%
|
$10,200
$34.42 P/Share
|
|
Nov 17
2021
|
Mark E Saad |
BUY
Open market or private purchase
|
Direct |
3,000
+23.07%
|
$102,000
$34.53 P/Share
|
|
May 12
2021
|
Mark Coleman |
BUY
Open market or private purchase
|
Indirect |
500
+0.12%
|
$29,000
$58.15 P/Share
|